Table of Content
Introduction
Primary Sclerosing Cholangitis - Overview
Primary Sclerosing Cholangitis - Therapeutics Development
Primary Sclerosing Cholangitis - Therapeutics Assessment
Primary Sclerosing Cholangitis - Companies Involved in Therapeutics Development
Primary Sclerosing Cholangitis - Drug Profiles
Primary Sclerosing Cholangitis - Dormant Projects
Primary Sclerosing Cholangitis - Discontinued Products
Primary Sclerosing Cholangitis - Product Development Milestones
Appendix
List of Figures
Number of Products under Development for Primary Sclerosing Cholangitis, 2021
Number of Products under Development by Companies, 2021
Number of Products by Top 10 Targets, 2021
Number of Products by Stage and Top 10 Targets, 2021
Number of Products by Top 10 Mechanism of Actions, 2021
Number of Products by Stage and Top 10 Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage Routes of Administration, 2021
Number of Products by Molecule Types, 2021
Number of Products by Stage and Top 10 Molecule Types, 2021
List of Tables
Number of Products under Development for Primary Sclerosing Cholangitis, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Companies, 2021 (Contd..1)
Number of Products under Development by Universities/Institutes, 2021
Products under Development by Companies, 2021
Products under Development by Companies, 2021 (Contd..1)
Products under Development by Companies, 2021 (Contd..2)
Products under Development by Universities/Institutes, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Target, 2021 (Contd..1)
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Mechanism of Action, 2021 (Contd..1)
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Primary Sclerosing Cholangitis - Pipeline by AbbVie Inc, 2021
Primary Sclerosing Cholangitis - Pipeline by Albireo Pharma Inc, 2021
Primary Sclerosing Cholangitis - Pipeline by Avolynt Inc, 2021
Primary Sclerosing Cholangitis - Pipeline by BiomX Inc, 2021
Primary Sclerosing Cholangitis - Pipeline by Cadila Healthcare Ltd, 2021
Primary Sclerosing Cholangitis - Pipeline by ChemomAb Ltd, 2021
Primary Sclerosing Cholangitis - Pipeline by CymaBay Therapeutics Inc, 2021
Primary Sclerosing Cholangitis - Pipeline by Dr. Falk Pharma GmbH, 2021
Primary Sclerosing Cholangitis - Pipeline by Emergent Biotechnologies LLC, 2021
Primary Sclerosing Cholangitis - Pipeline by Engitix Ltd, 2021
Primary Sclerosing Cholangitis - Pipeline by Gilead Sciences Inc, 2021
Primary Sclerosing Cholangitis - Pipeline by Hanmi Pharmaceuticals Co Ltd, 2021
Primary Sclerosing Cholangitis - Pipeline by HighTide Therapeutics Inc, 2021
Primary Sclerosing Cholangitis - Pipeline by Iltoo Pharma, 2021
Primary Sclerosing Cholangitis - Pipeline by Immunic Inc, 2021
Primary Sclerosing Cholangitis - Pipeline by Intercept Pharmaceuticals Inc, 2021
Primary Sclerosing Cholangitis - Pipeline by Mirum Pharmaceuticals Inc, 2021
Primary Sclerosing Cholangitis - Pipeline by NGM Biopharmaceuticals Inc, 2021
Primary Sclerosing Cholangitis - Pipeline by Nyrada Inc, 2021
Primary Sclerosing Cholangitis - Pipeline by Orbsen Therapeutics Ltd, 2021
Primary Sclerosing Cholangitis - Pipeline by Pliant Therapeutics Inc, 2021
Primary Sclerosing Cholangitis - Pipeline by Qing Bile Therapeutics Inc, 2021
Primary Sclerosing Cholangitis - Pipeline by Scohia Pharma Inc, 2021
Primary Sclerosing Cholangitis - Pipeline by Seres Therapeutics Inc, 2021
Primary Sclerosing Cholangitis - Pipeline by Sirnaomics Inc, 2021
Primary Sclerosing Cholangitis - Pipeline by Takeda Pharmaceutical Co Ltd, 2021
Primary Sclerosing Cholangitis - Pipeline by Yungjin Pharm Co Ltd, 2021
Primary Sclerosing Cholangitis - Dormant Projects, 2021
Primary Sclerosing Cholangitis - Discontinued Products, 2021